Alexander Alexandrov
Director
Medical Director
Maxwell Biotech Group
Russian Federation
Biography
Alexander has over 20 years of experience in biotech and pharmaceutical business. He is a Co-Founder and Director of Germany-based biotech firm Myr GmbH that develops first-in-class product for chronic Hepatitis B with Delta Agent. The firm’s product has successfully completed a clinical proof-of-concept study and currently is in phase 2b clinical trials.
Research Interest
Biotechnology, Clinical, Vaccines
